Prosserman Centre for Health Research, Samuel Lunenfeld Research Institute, 60 Murray St, Toronto M5T3L9, Canada.
BMC Cancer. 2010 Jun 14;10:285. doi: 10.1186/1471-2407-10-285.
BACKGROUND: We conducted a case-control study in the greater Toronto area to evaluate potential lung cancer risk factors including environmental tobacco smoke (ETS) exposure, family history of cancer, indoor air pollution, workplace exposures and history of previous respiratory diseases with special consideration given to never smokers. METHODS: 445 cases (35% of which were never smokers oversampled by design) between the ages of 20-84 were identified through four major tertiary care hospitals in metropolitan Toronto between 1997 and 2002 and were frequency matched on sex and ethnicity with 425 population controls and 523 hospital controls. Unconditional logistic regression models were used to estimate adjusted odds ratios (OR) and 95% confidence intervals (CI) for the associations between exposures and lung cancer risk. RESULTS: Any previous exposure to occupational exposures (OR total population 1.6, 95% CI 1.4-2.1, OR never smokers 2.1, 95% CI 1.3-3.3), a previous diagnosis of emphysema in the total population (OR 4.8, 95% CI 2.0-11.1) or a first degree family member with a previous cancer diagnosis before age 50 among never smokers (OR 1.8, 95% CI 1.0-3.2) were associated with increased lung cancer risk. CONCLUSIONS: Occupational exposures and family history of cancer with young onset were important risk factors among never smokers.
背景:我们在大多伦多地区进行了一项病例对照研究,以评估包括环境烟草烟雾(ETS)暴露、癌症家族史、室内空气污染、工作场所暴露和以前呼吸道疾病史在内的潜在肺癌危险因素,特别考虑了从不吸烟的人群。
方法:1997 年至 2002 年期间,在大都伦多地区的四家主要三级保健医院中,确定了年龄在 20-84 岁之间的 445 例病例(其中 35%为通过设计进行的从不吸烟者超额抽样),并根据性别和种族与 425 名人群对照和 523 名医院对照进行频率匹配。使用非条件逻辑回归模型来估计暴露与肺癌风险之间的关联的调整比值比(OR)和 95%置信区间(CI)。
结果:任何以前接触职业暴露(总人群 OR1.6,95%CI1.4-2.1,从不吸烟者 OR2.1,95%CI1.3-3.3)、总人群中以前肺气肿诊断(OR4.8,95%CI2.0-11.1)或从不吸烟者中一级亲属在 50 岁之前有癌症诊断史(OR1.8,95%CI1.0-3.2),与肺癌风险增加相关。
结论:职业暴露和癌症家族史与发病年龄早是从不吸烟者的重要危险因素。
Cancer Causes Control. 1999-12
Int J Cancer. 2006-4-1
Cancer Causes Control. 2012-5-22
Environ Res. 2016-2-11
Cancer Epidemiol Biomarkers Prev. 2006-4
Environ Health Perspect. 2011-11
BMC Cancer. 2022-12-6
Eur Respir Rev. 2022-9-30
N Engl J Med. 2009-9-3
Cancer Epidemiol Biomarkers Prev. 2008-11
J Physiol Pharmacol. 2007-11
Occup Environ Med. 2008-10
Br J Cancer. 2008-1-29
Nat Rev Cancer. 2007-10
J Natl Cancer Inst. 2007-5-2
J Clin Oncol. 2007-2-10
Am J Epidemiol. 2007-1-1